REFERENCES
- Gaw A., Docherty G., Brown E.A., Ford I. Predictors of Plasma Lipoprotein(a) Concentration in the West of Scotland Coronary Prevention Study Cohort. Atherosclerosis 1999; 143: 445–450
- Utermann G., Menzel H.J., Kraft H.G., Duba H.C., Kemmler H.G., Seitz C. Lp(a) Glycoprotein Phenotypes: Inheritance and Relation to Lp(a)-Lipoprotein Concentrations in Plasma. J. Clin. Invest. 1987; 80: 458–465
- Dieplinger H., Lackner C., Kronenberg F., Sandholzer C., Lhotta K., Hoppichler F., Graf H., Köning. Elevated Plasma Concentrations of Lipoprotein(a) Patients with End-Stage Renal Disease are not Related to the Size Polymorphism of Apolipoprotein(a). J. Clin. Invest. 1993; 91: 397–401
- McLean J.W., Tomlinson J.E., Kuang W.J., Eaton D.L., Chen E.Y. cDNA Sequence of Human Apolipoprotein(a) is Homologous to Plasminogen. Nature 1987; 330: 132–137
- Boerwinke I.E., Leffert C.C., Lin J., Lackner C., Chiesa G., Hobbs H.H. Apolipoprotein(a) Gene Accounts for Greater Than 90% of the Variation in Plasma Lipoprotein(a) Concentrations. J. Clin. Invest. 1992; 90: 52–60
- Kimak E., Solski J., Janicka L., Ksiażek A., Janicki K. Concentration of Lp(a) and Other Apolipoproteins in Predialysis, Hemodialysis, Chronic Ambulatory Peritoneal Dialysis and Post-Transplant Patients. Clin. Chem. Lab. Med. 2000; 38: 421–425
- Kimak E., Solski J., Janicka L. Lipoprotein Profiles at Different Stages of Chronic Renal Insufficiency (CRI). Renal Failure 2000; 22: 63–71
- Kronenberg F., König P., Neyer U., Auinger M., Pribasing A., Lang U. Multicenter Study of Lipoprotein(a) and Apolipoprotein(a) Phenotypes in Patients with End-Stage Renal Disease Treated by Hemodialysis or Continuous Ambulatory Peritoneal Dialysis. J. Am. Soc. Nephrol. 1995; 6: 110–120
- Kandoussi A.M., Huge V., Cachera C., Hazzan M., Dracon M., Tacquet A., Noël C. Apo(a) Phenotypes and Lp(a) Concentrations in Renal Transplant Patients. Nephron. 1998; 80: 183–187
- Kim S.B., Yang W.S., Kang E.S., Min W.K., Park J.S. Lipoprotein(a) and Apolipoprotein(a) Phenotypes in Patients with End-Stage Renal Disease. Perit. Dial. Int. 1997; 17: 236–242
- Milionis H.J., Elisaf M.S., Tselepis A., Bairaktari E., Karabina S.A., Siamopoulos K. Apolipoprotein(a) Phenotypes and Lipoprotein(a) Concentrations in Patients with Renal Failure. Am. J. Kid. Dis. 1999; 33: 1100–1106
- Wanner C., Bartens W., Walz G., Nauck M., Schollmeyer P. Protein Loss and Genetic Polymorphism of Apolipoprotein(a) Modulate Serum Lipoprotein(a) in CAPD Patients. Nephrol. Dial. Transplant. 1995; 10: 75–81
- Kronenberg F., Kuen E., Ritz E., Junker R., König P., Kraatz G., Lhotta K., Mann J.F.E., Müller G.A. Lipoproteina(a) Serum Concentrations and Apolipoprotein(a) Phenotypes in Mild and Moderate Renal Failure. J. Am. Soc. Nephrol. 2000; 11: 105–115
- Kronenberg F., Trenkwalder E., Lingenhel A., Fredrich G., Lhotta K., Schober M., Moes M., Köning P., Utermann G., Deplinger H. Renovascular Arteriovenous Differences in Lp(a) Plasma Concentrations Suggest Removal of Lp(a) from the Renal Circulation. J. Lipid. Res. 1997; 38: 1755–1763
- Arnadottir M., Berg A.L., Kronenberg F., Lingenhel A., Hugosson T., Hegbrant J., Nilsson-Ehle P. Corticotropin-Induced Reduction of Plasma Lipoprotein(a) Concentrations in Healthy Individuals and Hemodialysis Patients: Relation to Apolipoprotein(a) Size Polymorphism. Metabolism 1999; 48: 342–346
- Kronenberg F., Neyer U., Lhotta K., Trenkwalder E., Auinger M., Pribasnig A., Meisl T., Köning P., Deplinger H. The Low Molecular Weight Apo(a) Phenotype is an Independent Predictor for Coronary Artery Disease in Hemodialysis Patients: A Prospective Follow-up. J. Am. Soc. Nephrol. 1999; 10: 1027–1036
- Gazzaruso C., Geroldi D., Garzaniti A., Falcone C., Fratino P., Finardi G., Buscaglia P. Apolipoprotein(a) Phenotypes as Genetic Markers of Coronary Atherosclerosis Severity. Int. J. Cadiol. 1998; 64: 277–284